Impact of contraceptive initiation on vaginal microbiota
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Data evaluating the impact of contraceptives on the vaginal microbiome are limited and inconsistent. OBJECTIVE: We hypothesized that women initiating copper intrauterine device use would have increased bacterial vaginosis and bacterial vaginosis-associated microbes with use compared to women initiating and using hormonal contraceptive methods. STUDY DESIGN: Vaginal swabs (N = 1047 from 266 participants seeking contraception) for Nugent score determination of bacterial vaginosis and quantitative polymerase chain reaction analyses for assessment of specific microbiota were collected from asymptomatic, healthy women aged 18-35 years in Harare, Zimbabwe, who were confirmed to be free of nonstudy hormones by mass spectrometry at each visit. Contraception was initiated with an injectable (depot medroxyprogesterone acetate [n = 41], norethisterone enanthate [n = 44], or medroxyprogesterone acetate and ethinyl estradiol [n = 40]), implant (levonorgestrel [n = 45] or etonogestrel [n = 48]), or copper intrauterine device (n = 48) and repeat vaginal swabs were collected after 30, 90, and 180 days of continuous use. Self-reported condom use was similar across all arms at baseline. Quantitative polymerase chain reaction was used to detect Lactobacillus crispatus, L jensenii, L gasseri/johnsonii group, L vaginalis, L iners, Gardnerella vaginalis, Atopobium vaginae, and Megasphaera-like bacterium phylotype I from swabs. Modified Poisson regression and mixed effects linear models were used to compare marginal prevalence and mean difference in quantity (expressed as gene copies/swab) prior to and during contraceptive use. RESULTS: Bacterial vaginosis prevalence increased in women initiating copper intrauterine devices from 27% at baseline, 35% at 30 days, 40% at 90 days, and 49% at 180 days (P = .005 compared to marginal prevalence at enrollment). Women initiating hormonal methods had no change in bacterial vaginosis prevalence over 180 days. The mean increase in Nugent score was 1.2 (95% confidence interval, 0.5-2.0; P = .001) in women using copper intrauterine devices. Although the frequency and density of beneficial lactobacilli did not change among intrauterine device users over 6 months, there was an increase in the log concentration of G vaginalis (4.7, 5.2, 5.8, 5.9; P = .046) and A vaginae (3.0, 3.8, 4.6, 5.1; P = .002) between baseline and 30, 90, and 180 days after initiation. Among other contraceptive groups, women using depot medroxyprogesterone acetate had decreased L iners (mean decrease log concentration = 0.8; 95% confidence interval, 0.3-1.5; P = .004) and there were no significant changes in beneficial Lactobacillus species over 180 days regardless of contraceptive method used. CONCLUSION: Copper intrauterine device use may increase colonization by bacterial vaginosis-associated microbiota, resulting in increased prevalence of bacterial vaginosis. Use of most hormonal contraception does not alter vaginal microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
Romero, R., Hassan, S. S., Gajer, P., Tarca, A. L., Fadrosh, D. W., Nikita, L., Galuppi, M., Lamont, R. F., Chaemsaithong, P., Miranda, J., et al. (2014) · Microbiome · doi:10.1186/2049-2618-2-4 · Cited by 852
Koumans, E. H., Sternberg, M., Bruce, C., McQuillan, G., Kendrick, J., Sutton, M., & Markowitz, L. E. (2007) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318074e565 · Cited by 761 · cited 2×
“Understanding the impact of contraceptive initiation and use on vaginal microbiota is important since perturbations often cause distressing symptoms and bacterial vaginosis (BV) has been associated with increased risk of sexually transmitted infections,1-3 including HIV.4-6 Systematic review of studies evaluating the…”
Bacterial vaginosis and HIV acquisition: A meta-analysis of published studies
Atashili, J., Poole, C., Ndumbe, P. M., Adimora, A. A., & Smith, J. S. (2008) · AIDS · doi:10.1097/qad.0b013e3283021a37 · Cited by 706
Gosmann, C., Anahtar, M. N., Handley, S. A., Farcasanu, M., Abu-Ali, G., Bowman, B. A., Padavattan, N., Desai, C., Droit, L., Moodley, A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2016.12.013 · Cited by 696 · cited 2×
“ogy JUNE 2018 (L iners).(13,14) Gardnerella vaginalis and Atopobium vaginae were chosen as targets for this analysis because, in women with BV, they are the 2 most dominant members of the vaginal microbiota, and Megasphaera phylotype I was included because this novel species is specific to women with BV and is associa…”
BackgroundMethodEvaluation of Methods for the Extraction and Purification of DNA from the Human Microbiome
Yuan, S., Cohen, D. B., Ravel, J., Abdo, Z., & Forney, L. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033865 · Cited by 511
Borgdorff, H., Tsivtsivadze, E., Verhelst, R., Marzorati, M., Jurriaans, S., Ndayisaba, G. F., Schuren, F. H., & van de Wijgert, J. H. H. M. (2014) · The ISME Journal · doi:10.1038/ismej.2014.26 · Cited by 287 · cited 2×
“ogy JUNE 2018 (L iners).(13,14) Gardnerella vaginalis and Atopobium vaginae were chosen as targets for this analysis because, in women with BV, they are the 2 most dominant members of the vaginal microbiota, and Megasphaera phylotype I was included because this novel species is specific to women with BV and is associa…”
Polis, C. B., Curtis, K. M., Hannaford, P. C., Phillips, S. J., Chipato, T., Kiarie, J. N., Westreich, D. J., & Steyn, P. S. (2016) · AIDS · doi:10.1097/qad.0000000000001228 · Cited by 196 · cited 1×
“Systematic review of studies evaluating the risk of HIV acquisition and contraceptive use suggests that depot medroxyprogesterone acetate (DMPA) may increase the risk of HIV acquisition.(7) The possibility that contraceptive use may alter HIV susceptibility warrants further investigation of potential mechanisms, inclu…”
BackgroundBacterial Vaginosis and the Risk of Trichomonas vaginalis Acquisition Among HIV-1–Negative Women
Balkus, J. E., Richardson, B. A., Rabe, L. K., Taha, T. E., Mgodi, N., Kasaro, M. P., Ramjee, G., Hoffman, I. F., & Abdool Karim, S. S. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000075 · Cited by 89
Cited by
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Salliss, M. E., Farland, L. V., Mahnert, N. D., & Herbst-Kralovetz, M. M. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmab035 · Cited by 274
Cervicovaginal microbiota, women's health, and reproductive outcomes
Kroon, S. J., Ravel, J., & Huston, W. M. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.06.036 · Cited by 235
The Endometrial Microbiome and Its Impact on Human Conception
Toson, B., Simon, C., & Moreno, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23010485 · Cited by 131
“Strict inclusion and exclusion criteria considering hormonal treatment, antibiotic/ probiotic administration, and intrauterine devices should also be used because these interventions may influence results through changes in endometrial microbiome composition [17,27,29,30].”
BackgroundWessels, J. M., Felker, A. M., Dupont, H. A., & Kaushic, C. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035147 · Cited by 102
“Achilles, S. L., Austin, M. N., Meyn, L. A., Mhlanga, F., Chirenje, Z. M. andHillier, S. L. (2018).”
Metadata
- Authors
- Achilles, S. L., Austin, M. N., Meyn, L. A., Mhlanga, F., Chirenje, Z. M., & Hillier, S. L.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 218
- Issue
- 6
- Pages
- 622.e1-622.e10
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W2792717467
- Cited by
- 138
- References
- 9
- FWCI
- 10.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.